Status:
UNKNOWN
Secondary Obliteration of Old Radical Cavities Using S53P4 Bioactive Glass
Lead Sponsor:
Diakonessenhuis, Utrecht
Conditions:
Mastoid Cavity
Eligibility:
All Genders
Brief Summary
In canal wall down surgeries, the posterior bony wall of the external auditory canal (EAC) is removed to increase exposure. The creation of a so-called radical cavity comes with several possible disad...
Eligibility Criteria
Inclusion
- Old canal wall down cavity
- Operated between 2011 and 2022
Exclusion
- Middle ear cholesteatoma
- Previous obliteration
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2024
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT06116513
Start Date
January 1 2021
End Date
January 1 2024
Last Update
November 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diakonessenhuis
Utrecht, Netherlands, 3582KE